Regulation of Th1/Th17 cytokines and IDO gene expression by inhibition of calpain in PBMCs from MS patients

Amena W. Smith, Bently P. Doonan, William R. Tyor, Nada Abou-Fayssal, Azizul Haque, Naren L. Banik

Research output: Contribution to journalArticlepeer-review

32 Scopus citations

Abstract

Multiple sclerosis (MS) pathology is marked by the massive infiltration of myelin-specific T cells into the central nervous system (CNS). During active disease, pro-inflammatory Th1/Th17 cells predominate over immunoregulatory Th2/Treg cells. Here, we show that calpain inhibition downregulates Th1/Th17 inflammatory cytokines and mRNA in MS patient peripheral blood mononuclear cells (PBMCs) activated with anti-CD3/28 or MBP. Interestingly, calpain inhibition elevated IDO gene expression in MS PBMCs, which was markedly decreased in calpain expressing cells. Functional assay showed that incubation of MS patient PBMCs with calpain inhibitor or recombinant IDO attenuates T cell proliferation. These results suggest that calpain inhibition may attenuate MS pathology and augment the efficacy of standard immunomodulatory agents used to treat this disease.

Original languageEnglish
Pages (from-to)179-185
Number of pages7
JournalJournal of Neuroimmunology
Volume232
Issue number1-2
DOIs
StatePublished - Mar 2011
Externally publishedYes

Keywords

  • Calpain
  • Indoleamine 2, 3-dioxygenase
  • Multiple sclerosis
  • Peripheral blood mononuclear cells
  • Th17

Fingerprint

Dive into the research topics of 'Regulation of Th1/Th17 cytokines and IDO gene expression by inhibition of calpain in PBMCs from MS patients'. Together they form a unique fingerprint.

Cite this